2
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Current Papers in ME/CFS

Pages 121-128 | Published online: 04 Dec 2011

ASSESSMENT/DIAGNOSIS

  • (No authors listed) Chronic fatigue syndrome. Clinical practice guide-lines-2002. Med J Aust. 2002; 176 Suppl:S23–S56.
  • Alijotas J, Alegre J, Fernandez-Sola J, et al. Consensus report on the diagnosis and treatment of chronique fatigue syndrome in Catalonia, Spain. Med Clin-Barcelona 2002; 118:73–76.
  • Berner I, Gaubitz M, Jackisch C, et al. Comparative examination of complaints of patients with breast-cancer with and without silicone implants. Eur J Obstet Gyn R B 2002; 102:61–66.
  • Clauw D. Fibromyalgia associated syndromes. J Musculoskelet Pain 2002; 10:201–214.
  • Craig T, Kakumanu S. Chronic fatigue syndrome: evaluation and treatment. Am Fam Physician. 2002; 65:1083–1090.
  • Cullen W, Kearney Y, Bury G. Prevalence of fatigue in general prac-tice. Jr J Med Sci. 2002; 171:10–12.
  • de Vries M, Soetekouw PMMB, van der Meer JWM, et al. Physical ac-tivity and exercise performance in symptomatic Cambodia veterans. Q_jm-Mon J Assoc Phys 2002; 95:99–105.
  • Doebbeling BN, Jones MF, Hall DB, et al. Methodologic issues in a population-based health survey of Gulf War veterans. J Clin Epidemiol 2002; 55:477–487.
  • Garralda ME, Rangel L. Annotation: Chronic Fatigue Syndrome in children and adolescents. J Child Psychol Psychiatry 2002; 43:169–176.
  • Gray GC, Reed RJ, Kaiser KS, Smith TC, Gastanaga VM. Self-re-ported symptoms and medical conditions among 11,868 Gulf War-era veterans: the Seabee Health Study. Am J Epidemiol 2002; 155:1033–1044.
  • Herrell R, Goldberg J, Hartman S, et al. Chronic fatigue and chronic fatigue syndrome: a co-twin control study of functional status. Qual Life Res 2002; 11:463–471.
  • Jason LA, Taylor RR, Kennedy CL, Jordan K, Huang CF, Torres-Har-ding S, Song S, Johnson D. A factor analysis of chronic fatigue symp-toms in a community-based sample. Soc Psychiatry Psychiatr Epidemiol 2002; 37:183–189.
  • Jason LA, Torres-Harding SR, Carrico AW, Taylor RR. Symptom oc-currence in persons with chronic fatigue syndrome. Biol Psychol 2002; 59:15–27.
  • Linder R, Dinser R, Wagner M, Krueger GR, Hoffmann A. Generation of classification criteria for chronic fatigue syndrome using an artifi-cial neural network and traditional criteria set. In Vivo 2002; 16:37–43.
  • Richardson A. The symptoms and management of myalgic encephalo-myelitis. Nurs Times 2002; 98:32–35.
  • Sargent C, Scroop GC, Nemeth PM, Burnet RB, Buckley JD. Maximal oxygen uptake and lactate metabolism are normal in chronic fatigue syndrome. Med Sci Sports Exerc 2002; 34:51–56.
  • Servaes P, Prins J, Verhagen S, Bleijenberg G. Fatigue after breast cancer and in chronic fatigue syndrome. Similarities and differences. J Psychosom Res 2002; 52:453–459.
  • Sharpe M. The English Chief Medical Officer's Working Parties' re-port on the management of CFS/ME: significant breakthrough or un-satisfactory compromise? J Psychosom Res 2002; 52:437–438.
  • Snell CR, Vanness JM, Strayer DR, Stevens SR. Physical performance and prediction of 2-5A synthetase/RNase L antiviral pathway activity in patients with chronic fatigue syndrome. In Vivo 2002; 16:107–109.
  • Spath M. The chronic fatigue syndrome (CFS). Aktuel Rheumatol 2002; 27:90–96.
  • Stanley I, Salmon P, Peters S. Doctors and social epidemics: the prob-lem of persistent unexplained physical symptoms, including chronic fatigue. Br J Gen Pract 2002; 52:355–356.
  • Price EJ, Venables PJW. Dry eyes and mouth syndrome—a subgroup of patients presenting with sicca symptoms. Rheumatology 2002; 41: 416–422.
  • Tan EM, Sugiura K, Gupta S. The case definition of chronic fatigue syndrome. J Clin Immunol 2002; 22:8–12.
  • Taylor RR, Jason LA, Curie CJ. Prognosis of chronic fatigue in a com-munity-based sample. Psychosom Med 2002; 64:319–327.
  • van der Werf SP, de Vree B, van Der Meer JW, Bleijenberg G. The re-lations among body consciousness, somatic symptom report, and infor-mation processing speed in chronic fatigue syndrome. Neuropsychiatry Neuropsychol Behav Neurol 2002; 15:2–9.
  • van Houdenhove B. Listening to CFS—Why we should pay more atten-tion to the story of the patient? J Psychosom Res 2002; 52:495–499.
  • Whitehead WE, Palsson 0, Jones KR. Systematic review of the co-morbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 2002; 122:1140–1156.
  • Yunus MB. Gender differences in fibromyalgia and other related syn-dromes. J Gend Specif Med 2002; 5:42–47.
  • Zachrisson 0, Regland B, Jahreskog M, Kron M, Gottfries CG. A rat-ing scale for fibromyalgia and chronic fatigue syndrome (the Fibro-Fatigue scale). J Psychosom Res 2002; 52:501–509.

MICROBIOLOGY

  • Lerner MA, Beqaj SH, Deeter RG, Fitzgerald JT. IgM serum antibodies to human cytomegalovirus nonstructural gene products p52 and CM2 (UL44 and UL57) are uniquely present in a subset of patients with chronic fatigue syndrome. In Vivo 2002; 16:153–159.
  • Kerr JR, Bracewell J, Laing I, Mattey DL, Bernstein RM, Bruce IN, Tyr-rell DA. Chronic fatigue syndrome and arthralgia following parvovirus B19 infection. J Rheumatol 2002; 29:595–602.
  • Chemaly RF, Rehm SJ. Human herpesvirus 6-Reply. Clev Clin J Med 2002; 69:92–92.
  • Fox JD, Han S, Samuelson A, et al. Development and evaluation of nu-cleic acid sequence based amplification (NASBA) for diagnosis of enterovirus infections using the NucliSens (R) Basic Kit. J Clin Virol 2002; 24:117–130.

IMMUNOLOGY

  • Behan WMH, Chaudhuri A, Gow J, et al. Antiviral pathway activation in chronic fatigue syndrome and acute infection-Reply. Clin Infect Dis 2002; 34:1421–1422.
  • Brunet JL, Fatoohi F, Liaudet AP, Cozon GJ. Role of pathological de-layed-type hypersensitivity in chronic fatigue syndrome: importance of the evaluation of lymphocyte activation by flow cytometry and the mea-surement of urinary neopterin. Allerg Immunol (Paris) 2002; 34:38–44. (In French).
  • De Meirleir K, Suhadolnik RJ, Lebleu B, Englebienne P. Antiviral path-way activation in chronic fatigue syndrome and acute infection. Clin In-fect Dis 2002; 34:1420–1422.
  • Kowal K, Schacterele RS, Schur PH, Komaroff AL, DuBuske LM. Prevalence of allergen-specific IgE among patients with chronic fatigue syndrome. Allergy Asthma Proc 2002; 23:35–39.
  • Quan N, Herkenham M. Connecting cytokines and brain: a review of current issues. Histol Histopathol 2002; 17:273–288.
  • Repka-Ramirez S, Naranch K, Park YJ, Clauw D, Baraniuk JN. Cyto-kines in nasal lavage fluids from acute sinusitis, allergic rhinitis, and chronic fatigue syndrome subjects. Allergy Asthma Proc 2002; 23: 185–190.
  • Sabath DE, Barcy S, Koelle DM, Zeh J, Ashton S, Buchwald D. Cellular immunity in monozygotic twins discordant for chronic fatigue syn-drome. J Infect Dis 2002; 185:828–832.
  • Snell CR, Vanness JM, Strayer DR, Stevens SR. Physical performance and prediction of 2-5A synthetase/RNase L antiviral pathway activity in patients with chronic fatigue syndrome. In Vivo 2002; 16:107–109.
  • Shetzline SE, Martinand-Mari C, Reichenbach NL, Buletic Z, Lebleu B, Pfleiderer W, Charubala R, De Meirleir K, De Becker P, Peterson DL, Herst CV, Englebienne P, Suhadolnik RJ. Structural and functional fea-tures of the 37-kDa 2-5A-dependent RNase L in chronic fatigue syn-drome. J Interferon Cytokine Res 2002; 22:443–456.

PSYCHOSOMATIC

  • Asbring P, Narvanen AL. Women's experiences of stigma in relation to chronic fatigue syndrome and fibromyalgia. Quad Health Res 2002; 12: 148–160.
  • Gunstad J, Suhr JA. Perception of illness: nonspecificity of post-concussion syndrome symptom expectation. J Int Neuropsych Soc 2002; 8:37–47.
  • Jason LA, Taylor RR, Plioplys S, Stepanek Z, Shlaes J. Evaluating at-tributions for an illness based upon the name: chronic fatigue syn-drome, myalgic encephalopathy and Florence Nightingale disease. Am J Community Psychol 2002; 30:133–148.
  • Leavitt F, Katz RS, Mills M, et al. Cognitive and dissociative manifes-tations in fibromyalgia. J Clin Rheumatol 2002; 8:77–84.
  • Lehman AM, Lehman DR, Hemphill KJ, Mandel DR, Cooper LM. Ill-ness experience, depression, and anxiety in chronic fatigue syndrome. J Psychosom Res 2002; 52:461–465.
  • Metzger FA, Denney DR. Perception of cognitive performance in pa-tients with chronic fatigue syndrome. Ann Behav Med 2002; 24: 106–112.
  • Roy-Byrne P, Mari N, Ashton S, Fischer M, Goldberg J, Buchwald D. Chronic fatigue and anxiety/depression: a twin study. Br J Psychiatry 2002; 180:29–34.
  • Short K, McCabe M, Tooley G. Cognitive functioning in Chronic Fa-tigue Syndrome and the role of depression, anxiety, and fatigue. J Psychosom Res 2002; 52:475–483.
  • Silver A, Haeney M, Vijayadurai P, Wilks D, Pattrick M, Main CJ. The role of fear of physical movement and activity in chronic fatigue syndrome. J Psychosom Res 2002; 52:485–493.
  • Wilhelmsen I. Somatization, sensitization, and functional dyspepsia. Scand J Psychol 2002; 43:177–180.

PATHOPHYSIOLOGY

  • Bolt HM, Kiesswetter E. Is multiple chemical sensitivity a clinically defined entity? Toxicol Lett 2002; 128:99–106.
  • Clauw D. Fibromyalgia associated syndromes. J Musculoskelet Pain 2002; 10:201–214.
  • Crofford U. The hypothalamic-pituitary-adrenal axis in fibromyalgia: where are we in 2001? J Musculoskelet Pain 2002; 10:215–220.
  • Durlach J, Pages N, Bac P, Bara M, Guiet-Bara A. Biorhythms and possible central regulation of magnesium status, phototherapy, dark-ness therapy and chronopathological forms of magnesium depletion. Magnes Res 2002; 15:49–66.
  • Farquhar WB, Hunt BE, Taylor JA, Darling SE, Freeman R. Blood volume and its relation to peak 0(2) consumption and physical activity in patients with chronic fatigue. Am J Physiol Heart Circ Physiol 2002; 282:H66–H71.
  • Gaab J, Huster D, Peisen R, Engert V, Schad T, Schurmeyer TH, Ehlert U. Low-dose dexamethasone suppression test in chronic fatigue syndrome and health. Psychosom Med 2002; 64:311–318.
  • Paiva ES, Deodhar A, Jones KD, et al. Impaired growth hormone se-cretion in fibromyalgia patients—Evidence for augmented hypotha-lamic somatostatin tone. Arthritis Rheum 2002; 46:1344–1350.
  • Palaniappan R, Sirimanna T. Peripheral vestibular dysfunction in chronic fatigue syndrome. Int J Pediatr Otorhinolaryngol 2002; 64: 69–72.
  • Rowe PC. Orthostatic intolerance and chronic fatigue syndrome: new light on an old problem. J Pediatr 2002; 140:387–389.
  • Spath M. The chronic fatigue syndrome (CFS). Aktuel Rheumatol 2002; 27:90–96.
  • Tanaka H, Matsushima R, Tamai H, Kajimoto Y. Impaired postural cerebral hemodynamics in young patients with chronic fatigue with and without orthostatic intolerance. J Pediatr 2002; 140:412–417.
  • Winder C. Mechanisms of multiple chemical sensitivity. Toxicol Lett 2002; 128:85–97.

TREATMENT

  • (No authors listed) Information from your family doctor. Chronic fa-tigue syndrome: how to help yourself. Am Fam Physician 2002; 65:1095.
  • (No authors listed) Chronic fatigue syndrome. Clinical practice guide-lines-2002. Med J Aust 2002; 176 Suppl:S23–S56.
  • Alijotas J, Alegre J, Fernandez-Sola J, et al. Consensus report on the diagnosis and treatment of chronique fatigue syndrome in Catalonia, Spain. Med Clin-Barcelona 2002; 118:73–76.
  • Ax S, Gregg VH, Jones D. Caring for a relative with chronic fatigue syndrome: difficulties, cognition and acceptance over time. J R Soc Health 2002; 122:35–42.
  • Chalder T, Tong J, Deary V. Family cognitive behaviour therapy for chronic fatigue syndrome: an uncontrolled study. Arch Dis Child 2002; 86:95–97.
  • Clark C, Buchwald D, MacIntyre A, et al. Chronic fatigue syndrome: a step towards agreement. Lancet 2002; 359:97–98.
  • Collins JF, Donta ST, Engel CC, et al. The Antibiotic Treatment Trial of Gulf War Veterans' Illnesses: issues, design, screening, and base-line characteristics. Control Clin Trials 2002; 23:333–353.
  • Craig T, Kakumanu S. Chronic fatigue syndrome: evaluation and treatment. Am Fam Physician 2002; 65:1083–1090. Review.
  • Garralda ME, Rangel L. Annotation: Chronic Fatigue Syndrome in children and adolescents. J Child Psychol Psychiatry 2002; 43:169–176.
  • Green B. Focus on amisulpride. Curr Med Res Opin 2002; 18:113–117.
  • Hatcher S. Review: cognitive behavioural therapy and graded exercise show the most promise for chronic fatigue syndrome. Evid Based Ment Health 2002; 5:54.
  • Kinsella P. Review: behavioural interventions show the most promise for chronic fatigue syndrome. Evid Based Nurs 2002; 5:46.
  • Kisely S. Treatments for chronic fatigue syndrome and the Internet: a systematic survey of what your patients are reading. Aust N Z J Psy-chiatry 2002; 36:240–245.
  • Kmietowicz Z. Cognitive behaviour therapy and exercise are the only effective treatments for chronic fatigue, says study. BMJ 2002; 324:1298.
  • Lacour M, Zunder T, Dettenkofer M, Schonbeck S, Ludtke R, Scheidt C. An interdisciplinary therapeutic approach for dealing with patients attributing chronic fatigue and functional memory disorders to envi-ronmental poisoning—a pilot study. Int J Hyg Environ Health 2002; 204:339–346.
  • Lim A, Lubitz L. Chronic fatigue syndrome: successful outcome of an intensive inpatient programme. J Paediatr Child Health 2002; 38: 295–299.
  • Looper KJ, Kirmayer U. Behavioral medicine approaches to somato-form disorders. J Consult Clin Psychol 2002; 70:810–827. Review.
  • Richardson A. The symptoms and management of myalgic enceph-alomyelitis. Nurs Times 2002; 98:32–35.
  • Sharpe M. The English Chief Medical Officer's Working Parties' re-port on the management of CFS/ME: significant breakthrough or un-satisfactory compromise? J Psychosom Res 2002; 52:437–438.
  • Smith RC. Review: behavioral interventions show the most promise for the chronic fatigue syndrome. ACP J Club 2002; 136:61.
  • Straus SE. Caring for patients with chronic fatigue syndrome—Conclu-sions in CMO's report are shaped by anecdote not evidence. Brit Med J 2002; 324:124–125.
  • Tamizi far B, Tamizi B. Treatment of chronic fatigue syndrome by di-etary supplementation with omega-3 fatty acids—a good idea? Med Hypotheses 2002; 58:249–50.
  • Walach H, Bosch H, Haraldsson E, Marx A, Tomasson H, Wiesen-danger H, Lewith G. Efficacy of distant healing—A proposal for a Four-Armed Randomized Study (EUHEALS). Forsch Komplement-armed Mass Naturheilkd 2002; 9:168–176.

OTHER

  • Brage S. Utilization of national insurance in connection with functional somatic disorders. Tidsskr Nor Laegeforen 2002; 122:1397–1401.
  • Pastel RH. Radiophobia: long-term psychological consequences of Chernobyl. Mil Med 2002; 167:134–136.
  • Peduzzi P, Guarino P, Donta ST, et al. Research on informed consent: investigator-developed versus focus group-developed consent docu-ments, a VA cooperative study. Control Clin Trials 2002; 23:184–197.
  • Setness PA, Mettner J. Patient notes: chronic fatigue syndrome. Postgrad Med 2002; 111:137–138.
  • Tournier JN, Drouet E, Jouan A. The Gulf war syndrome. Presse Med 2002; 31:3–9. (In French).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.